NRG And Curium Sign Contract For Production of Mo-99 NRG (ENS Corporate Member) and Curium have signed a multi-year contract for the production of molybdenum-99, the starting material for technetium-99m (Tc-99m). Tc-99m is the most used isotope in nuclear medicine for diagnosing life-threatening diseases, such as cardiovascular diseases, lung and brain disorders and cancer. With…
Dutch Cabinet Supports Construction Of PALLAS Research Reactor The Dutch Minister of Health, Welfare and Sport Ernst Kuipers recently announced, that money has been set aside for the construction of the PALLAS reactor in Petten, North Holland, in the coming years. The ministry is reserving 30 million euros for the project this year and 129…
Medical Isotopes – International Experts Call For Action To Secure Supply International experts from irradiating reactors, other isotope producers, and direct users urgently call for a long-term strategy to prevent a critical shortage of research and production capacities. They jointly ask for a common framework that stimulates much needed policy changes and investments. The high-level…
Actinium-225, The Joint-Venture Pantera To Secure Its Production The Belgian Nuclear Research Centre SCK CEN (ENS Corporate Member) and IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology, announced last week the name of their joint-venture: Pantera SA/NV, resulting from strategic R&D partnership between SCK CEN and IBA to enable the production…
Commercial Production Of Lutetium-177 Starts At Bruce NPP The international collaboration between Bruce Power, Isogen (a Kinectrics and Framatome company) and ITM Isotope Technologies Munich SE (ITM) announced today the start of commercial production of lutetium-177. It marks the first-of-its-kind achievement of a commercial power reactor with additional capability to commercially produce short-lived medical isotopes.…
Wales Unveils Plans For Its New Nuclear Medicine Facility The Welsh Government has recently unveiled its major plans for the new national nuclear medicine laboratory, which aims at making Wales a global centre of excellence and the leading location for medical radioisotope production in the UK. The Project ARTHUR (Advanced Radioisotope Technology for Health Utility Reactor)…
Urenco Stable Isotopes Joins UNRANU Research Programme Urenco (ENS Corporate Member) Stable Isotopes recently joined the Understanding the Radiobiology of therapeutic medical radionuclides (UNRANU) programme as a consortium partner. The UNRANU programme is developing new production routes for radionuclides; finding the best match between radionuclide and tumour type, determining the optimal treatment dose, and investigating…
Mo-99 Ready To Be Produced At Darlington NPP The Darlington Nuclear Power Plant, located in Canada and operated by Ontario Power Generation (OPG), is now ready to produce life-saving Molybdenum-99 (Mo-99) isotopes, Laurentis Energy Partners and BWXT Medical Ltd announced last week. Thanks to the installation and initial commissioning of an innovative isotope system made…
SCK CEN And IRE Starts The Construction Of RECUMO Facility SCK CEN (ENS Corporate Member) and IRE – Institut National des Radioéléments inaugurated the construction of the RECUMO facility. The joint project represents the structural solution for the management of all of the highly radioactive residues stored at the IRE’s site in Fleurus (Belgium) which…
“What can I do to help improve patients’ lives?” Interview with Katya Popova, Researcher at the Institute for Nuclear Research and Nuclear Energy, Sofia Exciting recent developments in nuclear medicine provide effective cancer treatment in an ever more targeted way with minimal side effects. Today we talk with Katya Popova, Ph.D. in Genetics, and working…